| 出版应用/物种/样本/稀释 | 参考文献 |
|---|
| Khalil S, Delehanty L, Grado S, Holy M, White Z, Freeman K, et al. Iron modulation of erythropoiesis is associated with Scribble-mediated control of the erythropoietin receptor. J Exp Med. 2018;215:661-679 pubmed 出版商 |
- 免疫沉淀; 人类; 图 5d
- 免疫印迹; 人类; 图 5d
| Marcassa E, Raimondi M, Anwar T, Eskelinen E, Myers M, Triolo G, et al. Calpain mobilizes Atg9/Bif-1 vesicles from Golgi stacks upon autophagy induction by thapsigargin. Biol Open. 2017;6:551-562 pubmed 出版商 |
| Å talekar M, Yin X, Rebolj K, Darovic S, Troakes C, Mayr M, et al. Proteomic analyses reveal that loss of TDP-43 affects RNA processing and intracellular transport. Neuroscience. 2015;293:157-70 pubmed 出版商 |
| Facciuto F, Bugnon Valdano M, Marziali F, Massimi P, Banks L, Cavatorta A, et al. Human papillomavirus (HPV)-18 E6 oncoprotein interferes with the epithelial cell polarity Par3 protein. Mol Oncol. 2014;8:533-43 pubmed 出版商 |
| Ding X, Jiang X, Tian R, Zhao P, Li L, Wang X, et al. RAB2 regulates the formation of autophagosome and autolysosome in mammalian cells. Autophagy. 2019;:1-13 pubmed 出版商 |
| Shapiro J, Chung W, Ogawa K, Barker L, Carlson R, Wands J, et al. Identification of Tumor Antigen AF20 as Glycosylated Transferrin Receptor 1 in Complex with Heat Shock Protein 90 and/or Transporting ATPase. PLoS ONE. 2016;11:e0165227 pubmed 出版商 |
| Wan C, Fu J, Wang Y, Miao S, Song W, Wang L. Exosome-related multi-pass transmembrane protein TSAP6 is a target of rhomboid protease RHBDD1-induced proteolysis. PLoS ONE. 2012;7:e37452 pubmed 出版商 |
| Mortera Blanco T, Rende M, Macedo H, Farah S, Bismarck A, Mantalaris A, et al. Ex vivo mimicry of normal and abnormal human hematopoiesis. J Vis Exp. 2012;: pubmed 出版商 |
| Liu B, Zheng Y, Wang T, Xu H, Xia L, Zhang J, et al. Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells. J Proteome Res. 2012;11:1773-81 pubmed 出版商 |
| Mössner E, Brünker P, Moser S, Püntener U, Schmidt C, Herter S, et al. Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity. Blood. 2010;115:4393-402 pubmed 出版商 |
